Home / Taiwan Excellence Award / Award Winning Products / Product Details

PixoTest® Vision Analysis System (Lipid)
Industry type:Health and precision instrument
Product model number:VIS-C01 / CDM-C01
iXensor Co., Ltd.
award 3

The information related to this product could not be shown due to medical law, please contact the company directly for more information.

http://www.ixensor.com

Contact online

About iXensor Co., Ltd.

iXensor, the pioneer of mobile health, turns smartphones into lab-grade medical diagnostics, democratizing medical tests for the public. In 2017, iXensor introduced the PixoTest® Blood Glucose Monitoring System as the world's first US FDA-approved smartphone camera-based blood test. Based on the core PixoTech® platform, iXensor has ventured into at-home self-testing and clinical point-of-care diagnostics with product brand, PixoTest®, across infectious diseases, chronic diseases and Eveline® for women's health. In addition to their own brand products, iXensor actively engages in technology licensing, co-developments, and Contract Development and Manufacturing Services to drive the growth of connected healthcare solutions.

http://www.ixensor.com

PixoTestR represents iXensor's mobile diagnostics' product line, signifying our digital color and image sensing technology. The word "Pixo'' sheds light on its pioneering position as the world's first US FDA approved image quantification technology for smartphone-based medical tests; and "Test" pinpoints its core strength of decentralizing quality medical testing for billions of mobile devices users. The brand conveys infinite possibilities of "personalized digital healthcare." Since its launch in 2017, PixoTestR unleashed the unique advantage of decentralized medical testing, transforming the traditional healthcare model, which relies heavily on hospitals and clinics, in Europe, Africa and Taiwan. PixoTestR completes several innovative healthcare models such as at-home care and telemedicine, by making decentralized and connected medical testing possible with its rapid diagnostics for patients of chronic diseases and infectious diseases in the international realm of digital health.